Arsil%2525252525252525252525252525252525252525252520dx

# Arsil-DX (Guaifenesin/Dextromethorphan) ## Overview Arsil-DX is a combination non-prescription medication containing **guaifenesin** (an expectorant that thins mucus) and **dextromethorphan HBr** (a cough suppressant). It is formulated for the temporary relief of coughs due to minor throat/bronchial irritation and the loosening of phlegm associated with the common cold. ## Primary Indications * Temporary relief of coughs triggered by the common cold or inhaled irritants. * Assistance in clearing bronchial passages by thinning bronchial secretions. ## Adult Dosing * **Standard Dose:** 10 mL to 20 mL (containing equivalent of 200–400 mg guaifenesin / 20–40 mg dextromethorphan) orally every 4 to 6 hours as needed. * **Maximum Dose:** Do not exceed 60 mL to 80 mL in 24 hours (check specific label concentration for mg limits; typically max 2400 mg guaifenesin/240 mg dextromethorphan per 24 hours). ## Pediatric Dosing * **Children 6 to 12 years:** 5 mL to 10 mL orally every 4 to 6 hours. Do not exceed 4 doses in 24 hours. * **Children 4 to 6 years:** Only as directed by a physician. * **Children <4 years:** **Avoid use.** Safety and efficacy are not established; risk of serious adverse events including over-sedation. ## Dose Adjustments * **Renal/Hepatic Impairment:** No standard adjustments defined, but use with caution in patients with severe hepatic impairment due to dextromethorphan metabolism. * **Geriatric:** Start at the lower end of the dosing range due to increased sensitivity to anticholinergic-like effects and potential cognitive impairment. ## Contraindications * **MAO Inhibitors:** Do not use if the patient is currently taking or has taken an MAOI within the last 14 days (risk of serotonin syndrome). * **Hypersensitivity:** Known allergy to guaifenesin or dextromethorphan. ## Adverse Effects * **Gastrointestinal:** Nausea, vomiting, abdominal pain (frequently associated with guaifenesin). * **Neurological:** Dizziness, drowsiness, mild lightheadedness. * **Rare:** Serotonin syndrome (if combined with other serotonergic agents), constipation. ## Key Drug Interactions * **MAOIs:** Fatal reactions reported (see Contraindications). * **CNS Depressants:** Alcohol, sedatives, or hypnotics may potentiate drowsiness. * **SSRIs/SNRIs:** Potential risk for serotonin syndrome when taken with dextromethorphan. ## Monitoring * **Efficacy:** Monitor for reduction in cough frequency and improved ability to clear mucus. * **Safety:** Monitor for persistent symptoms beyond 7 days or presence of high fever. * **Red Flags:** Discontinue and seek medical evaluation if cough is accompanied by rash, persistent headache, or if the cough is chronic (e.g., asthma, emphysema). ## Clinical Pearls * **Hydration:** Emphasize the importance of increased fluid intake to maximize the mucolytic effect of guaifenesin. * **Product Variation:** Concentrations of "Arsil-DX" may vary by manufacturer or region; always verify the mg/mL strength on the bottle labels before calculating volume. * **Combination Products:** Counsel patients to avoid doubling up on other cold/cough products (such as NyQuil or Mucinex DM) to prevent unintentional dextromethorphan overdose. * **Dextromethorphan Abuse:** Be aware that dextromethorphan in high doses has potential for misuse; monitor for signs of diversion or excessive refill requests. *** *Disclaimer: This information is for educational purposes only. Always verify current prescribing information, local clinical guidelines, and specific product labeling before administering or recommending any medication.*